ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0001104.1|Myxovirescin_1 # 1 # 744 # -1 # ID=1_1;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.645	BGC0001104.1|Myxovirescin_1 	1	744	-	Loose	600	25.0238	Acinetobacter baumannii AmvA	33.33	3004577	protein homolog model	n/a	n/a	macrolide antibiotic; disinfecting agents and antiseptics	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGCGCCGGTGGTCACGCTCCATGAGGTGGAGGAGGGGGTGGCGCAGATCACCCTGGTGGATCGCGAGAACAAGAACATGTTCAGCGAGCAGCTCGTGCGCGAGCTCATCACCGTGTTCGGCAAGGTGAATGGAAACGAGCGCTACCGCGCGGTGGTGCTCACCGGCTACGACACCTACTTCGCGCTCGGCGGGACCAAGGCCGGCCTGCTGTCCATCTGCGACGGCATCGGCTCCTTCAACGTCACCAACTTCTACAGCCTCGCGCTGGAGTGCGACATCCCGGTGATTTCCGCCATGCAGGGACATGGCGTAGGCGGCGGGTTCGCGATGGGGCTGTTCGCGGACTTCGTGGTCCTGAGCCGGGAGAGCGTCTACACGACGAACTTCATGCGCTACGGCTTCACGCCGGGGATGGGCGCCACGTACATCGTGCCGAAGCGGCTGGGGTACTCGCTCGGGCATGAGCTCCTGCTCAACGCCAGGAACTACCGCGGCGCCGACCTGGAGAAGCGGGGCGTGCCTTTTCCGGTGTTGCCGCGCAAGGAAGTCTTGCCCCACGCCTACGAGATTGCGAGGGACCTGGCCGCGAAACCTCGGCTGTCGCTCGTGACGCTCAAGCGGCACCTGGTTCGCGACATCCGCCGAGAGCTTCCGGACGTCATCGAGCGTGAGCTGGAGATGCACGGCATCACCTTCCATCACGACGACGTGAGGAGGCGCATCGAGCAGCTGTTCCTCTGA	MAPVVTLHEVEEGVAQITLVDRENKNMFSEQLVRELITVFGKVNGNERYRAVVLTGYDTYFALGGTKAGLLSICDGIGSFNVTNFYSLALECDIPVISAMQGHGVGGGFAMGLFADFVVLSRESVYTTNFMRYGFTPGMGATYIVPKRLGYSLGHELLLNARNYRGADLEKRGVPFPVLPRKEVLPHAYEIARDLAAKPRLSLVTLKRHLVRDIRRELPDVIERELEMHGITFHHDDVRRRIEQLFL	MQKKWLILTIIVLIYLPVTIDATVMHVATPSLSAALNLTANQLLWIIDIYSLIMAGLILPMGALGDRIGFKKLLFIGTAVFGVGSLAAAFSPTAYALIASRAILGLGAAMLIPATLSGIRNAFTEEKQRNFALGIWSTVGGGGAAFGPLVGGFVLEHFHWGAVFLINIPIILAVLVMIVMIIPKQQEKTDQPINLGQALVLVVAILSLIYSIKSAMYNFSVLTVVMFVVGISTLIHFIRSQKRATTPMIDLELFKHPVISTSIVMAVVSMIALVGFELLLSQELQFVHGFSPLQAAMFIIPFMIAISLGGPLAGICLNKWGLRRVSSLGILVSALSLWGLAQLNFSTDHFLAWTCMVFLGFSIEIALLASTAAIMSSVPPQKASAAGAIEGMAYELGAGLGVAIFGLMLSWFYSRSIILPAELPSNLIEKASISIGETMQLASNLENPLGGQLIVVAQQAFSYAHSWVLTLSAICFFLLTVFVWFSFPKKVN	50.20	gnl|BL_ORD_ID|2718|hsp_num:0	3280			861	966	erythromycin; acriflavine
BGC0001104.1|Myxovirescin_2 # 759 # 1547 # -1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=11-12bp;gc_cont=0.672	BGC0001104.1|Myxovirescin_2 	759	1547	-	Loose	750	25.7942	bmr	31.71	3003007	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; nucleoside antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGCAAGCCGCTTCCCCTCCGCACCGCGACTACCAGACGCTCCGGGTCCGCTTCGAGGCGCAGACCTGTTTTCTCCAGCTCCACCGGCCGGATGCGGACAACACCATCAGCCGCACGCTGATTGACGAGTGCCAGCAGGTGCTCACGTTATGTGAGGAGCACGCCACCACGGTGGTGCTCGAAGGCCTGCCACACGTGTTCTGCATGGGCGCGGATTTTCGAGCCATCCACGACCGGGTCGACGACGGCCGCCGGGAGCAAGGCAACGCGGAGCAGCTGTACCGGCTGTGGCTGCAACTGGCGACAGGCCCCTACGTGACGGTCGCCCATGTGCAGGGCAAGGCCAACGCGGGCGGCCTGGGCTTCGTCGCCGCGTGCGACATCGTGCTGGCAAAGGCGGAGGTCCAGTTCAGTCTCTCCGAGCTGCTGTTCGGGCTGTTCCCCGCCTGCGTGATGCCGTTCCTCGCCCGGCGAATCGGCATCCAGCGGGCGCACTACCTGACGCTGATGACGCGGCCCATCGACGCGGCCCAGGCGCTGAGCTGGGGGTTGGCGGACGCGGTGGACGCCGATAGCGAGAAGCTGTTGCGGCTCCACTTGCGCAGGCTGCGGTGCCTGTCGAAGCCAGCGGTGACCCAGTACAAGAAGTACGCCTCCGAGCTGGGCGGCCAGCTGCTCGCGGCCATGCCCCGGGCCATCTCCGCCAATGAGGCGATGTTCTCCGACCGCGCCACGCTGGAAGCCATCCATCGCTACGTGGAGACAGGCCGACTCCCATGGGAATCATGA	MQAASPPHRDYQTLRVRFEAQTCFLQLHRPDADNTISRTLIDECQQVLTLCEEHATTVVLEGLPHVFCMGADFRAIHDRVDDGRREQGNAEQLYRLWLQLATGPYVTVAHVQGKANAGGLGFVAACDIVLAKAEVQFSLSELLFGLFPACVMPFLARRIGIQRAHYLTLMTRPIDAAQALSWGLADAVDADSEKLLRLHLRRLRCLSKPAVTQYKKYASELGGQLLAAMPRAISANEAMFSDRATLEAIHRYVETGRLPWES	MEKKNITLTILLTNLFIAFLGIGLVIPVTPTIMNELHLSGTAVGYMVACFAITQLIVSPIAGRWVDRFGRKIMIVIGLLFFSVSEFLFGIGKTVEMLFISRMLGGISAPFIMPGVTAFIADITTIKTRPKALGYMSAAISTGFIIGPGIGGFLAEVHSRLPFFFAAAFALLAAILSILTLREPERNPENQEIKGQKTGFKRIFAPMYFIAFLIILISSFGLASFESLFALFVDHKFGFTASDIAIMITGGAIVGAITQVVLFDRFTRWFGEIHLIRYSLILSTSLVFLLTTVHSYVAILLVTVTVFVGFDLMRPAVTTYLSKIAGNEQGFAGGMNSMFTSIGNVFGPIIGGMLFDIDVNYPFYFATVTLAIGIALTIAWKAPAHLKAST	67.35	gnl|BL_ORD_ID|1152|hsp_num:0	1256			210	333	acriflavine; puromycin; chloramphenicol
BGC0001104.1|Myxovirescin_5 # 4872 # 6299 # -1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.650	BGC0001104.1|Myxovirescin_5 	4872	6299	-	Loose	1000	30.8018	msbA	48.0	3003950	protein homolog model	n/a	n/a	nitroimidazole antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGGGGACCTCAGAGCCAGTTGAGCCGGACCACGCCTTGTCAAAACCACCGCCTGTCGCGCCCGTCGGCGCCCAGGCACTGCCTCGCGGTCCGGCAATGCCCGGCATCGCGCAGTTGATGATGTTGTTCCTGCGGCCCACGGAGTTCCTGGACCGCTGCGCCGCCCGGTACGGTGACACCTTCACCCTCAAGATTCCGGGGACGCCGCCGTTCATCCAGACCAGCGATCCCGCCTTGATCGAGGTCATCTTCAAGGGTGACCCGGACCTCTTCCTCGGAGGGAAGGCGAACAACGGGTTGAAGCCGGTGGTGGGTGAGAACTCGCTGCTGGTGTTGGACGGGAAGCGGCACCGGCGTGATCGCAAGCTCATCATGCCCACCTTCCTGGGTGAACGGATGCATGCGTATGGCTCGGTCATCCGGGACATCGTCAATGCGGCGCTTGACCGGTGGCCCGTCGGGAAGCCGTTCGCGGTCCATGAAGAGACGCAGCAGATCATGCTGGAGGTGATTCTCCGGGTGATTTTCGGCCTGGAGGACGCCCGGACCATTGCCCAGTTCCGGCACCACGTGCACCAGGTGCTCAAGCTGGCCCTGTTCCTGTTCCCGAACGGGGAGGGCAAGCCCGCCGCCGAGGGCTTCGCGCGGGCCGTGGGCAAGGCGTTTCCCTCCCTGGACGTGTTCGCGTCGCTGAAGGCGATTGACGACATCATCTACCAGGAGATTCAGGACCGCCGGAGCCAGGACATCAGCGGGCGGCAGGACGTGCTCTCGCTGATGATGCAGTCGCACTACGACGACGGCTCCGTGATGACGCCCCAGGAGCTGCGCGACGAGCTGATGACGCTGCTGATGGCGGGCCACGAGACGAGCGCGACCATCGCCGCGTGGTGCGTCTACCACCTCTGCCGTCACCCGGATGCGATGGGCAAGCTGCGTGAGGAGATCGCGGCCCACACGGTGGACGGCGTGCTGCCGCTGGCGAAGATCAACGAGCTGAAGTTCCTGGATGCCGTGGTCAAGGAGACGATGCGCATCACGCCCGTCTTCAGCCTGGTGGCTCGCGTGCTCAAGGAGCCACAGACCATTGGCGGAACGACGTACCCGGCGAACGTGGTGCTGTCGCCCAACATCTACGGCACGCACCATCGCGCGGACCTGTGGGGAGACCCGAAGGTCTTTCGGCCAGAGCGTTTCCTGGAGGAGCGGGTGAATCCGTTCCACTACTTCCCCTTCGGAGGGGGCATCCGGAAGTGCATCGGGACGAGCTTCGCCTACTACGAGATGAAGATCTTCGTCTCGGAGACGGTGCGCCGCATGCGCTTCGATACCAGGCCCGGCTACCACGCGAAGGTGGTGCGCCGGAGCAACACGCTGGCGCCGTCTCAGGGCGTGCCCATCATCGTCGAGTCGCGGCTGCCGAGCTGA	MGTSEPVEPDHALSKPPPVAPVGAQALPRGPAMPGIAQLMMLFLRPTEFLDRCAARYGDTFTLKIPGTPPFIQTSDPALIEVIFKGDPDLFLGGKANNGLKPVVGENSLLVLDGKRHRRDRKLIMPTFLGERMHAYGSVIRDIVNAALDRWPVGKPFAVHEETQQIMLEVILRVIFGLEDARTIAQFRHHVHQVLKLALFLFPNGEGKPAAEGFARAVGKAFPSLDVFASLKAIDDIIYQEIQDRRSQDISGRQDVLSLMMQSHYDDGSVMTPQELRDELMTLLMAGHETSATIAAWCVYHLCRHPDAMGKLREEIAAHTVDGVLPLAKINELKFLDAVVKETMRITPVFSLVARVLKEPQTIGGTTYPANVVLSPNIYGTHHRADLWGDPKVFRPERFLEERVNPFHYFPFGGGIRKCIGTSFAYYEMKIFVSETVRRMRFDTRPGYHAKVVRRSNTLAPSQGVPIIVESRLPS	MHNDKDLSTWQTFRRLWPTIAPFKAGLIVAGVALILNAASDTFMLSLLKPLLDDGFGKTDRSVLVWMPLVVIGLMILRGITSYVSSYCISWVSGKVVMTMRRRLFGHMMGMPVSFFDKQSTGTLLSRITYDSEQVASSSSGALITVVREGASIIGLFIMMFYYSWQLSIILIVLAPIVSIAIRVVSKRFRNISKNMQNTMGQVTTSAEQMLKGHKEVLIFGGQEVETKRFDKVSNRMRLQGMKMVSASSISDPIIQLIASLALAFVLYAASFPSVMDSLTAGTITVVFSSMIALMRPLKSLTNVNAQFQRGMAACQTLFTILDSEQEKDEGKRVIERATGDVEFRNVTFTYPGRDVPALRNINLKIPAGKTVALVGRSGSGKSTIASLITRFYDIDEGEILMDGHDLREYTLASLRNQVALVSQNVHLFNDTVANNIAYARTEQYSREQIEEAARMAYAMDFINKMDNGLDTVIGENGVLLSGGQRQRIAIARALLRDSPILILDEATSALDTESERAIQAALDELQKNRTSLVIAHRLSTIEKADEIVVVEDGVIVERGTHNDLLEHRGVYAQLHKMQFGQ	81.62	gnl|BL_ORD_ID|2185|hsp_num:0	2423			1389	1464	metronidazole
BGC0001104.1|Myxovirescin_6 # 6348 # 6863 # -1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.622	BGC0001104.1|Myxovirescin_6 	6348	6863	-	Loose	400	24.6386	MUS-2	52.63	3003842	protein homolog model	n/a	n/a	carbapenem; penam; penem	antibiotic inactivation	MUS beta-lactamase	ATGAACACTCCTTCCTTGACGAACTGGCCTGCCCGCCTGGGCTATCTCCTTGCCGTTGGCGGCGCATGGTTCGCGGCCGATCAAGTCACCAAACAGATGGCGCGCGACGGGGCGAAAAGGCCCGTCGCGGTCTTCGATAGCTGGTGGCACTTCCACTACGTGGAGAACCGAGCGGGTGCGTTCGGTCTGTTCTCCAGCTTCGGCGAAGAGTGGCGCATGCCTTTCTTCTACGTCGTGGGCGCCATCTGCATCGTGTTGCTGATTGGCTACTACTTCTACACGCCGCCGACGATGAAGCTCCAGCGCTGGTCGCTGGCGACGATGATTGGCGGCGCGTTGGGCAACTACGTGGACCGGGTGCGCCTGCGCTACGTGGTGGATTTCGTGTCATGGCACGTGGGGGACCGCTTCTATTGGCCCTCCTTCAACATCGCGGACACAGCGGTAGTCGTAGGGGCCGCCCTGATGATCCTGGAGTCGTTCCGCGAGCCGCGTCAGCAGTTGTCTCCCGGATAG	MNTPSLTNWPARLGYLLAVGGAWFAADQVTKQMARDGAKRPVAVFDSWWHFHYVENRAGAFGLFSSFGEEWRMPFFYVVGAICIVLLIGYYFYTPPTMKLQRWSLATMIGGALGNYVDRVRLRYVVDFVSWHVGDRFYWPSFNIADTAVVVGAALMILESFREPRQQLSPG	MHRILSVITMLICTTLVHAQSDKLKIKQLNDNMYIYTTYQEFQGVTYSSNSMYVLTDEGAILIDTPWDKDQYEPLLEYIRSNHNKEVKWVITTHFHEDRSGGLGYFNSIGAQTYTYALTNEILKERNEPQAQYSFNKEKQFTFGNEKLAVYFLGEGHSLDNTVVWFPKEEVLYGGCLIKSAEATTIGNIADGNVIAWPKTIEAVKQKFKNAKVIIPGHDEWDMIGHIENTERILSAYNQQHSTKND	69.51	gnl|BL_ORD_ID|2113|hsp_num:0	2328			279	330	amoxicillin; piperacillin; ticarcillin
BGC0001104.1|Myxovirescin_7 # 6891 # 8141 # -1 # ID=1_7;partial=00;start_type=GTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.667	BGC0001104.1|Myxovirescin_7 	6891	8141	-	Loose	300	28.8758	AAC(3)-VIa	32.61	3002540	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(3)	GTGGCTGAGCGGGTTCCCGGCGGAGTCGGCATCGAGGCCATCAACGCCTACGGCGGCGCCGCCTCCATTCCGGTGTTGGACTTGTTCCGGGGCCGGCGGCTGGACCCCGAGCGATTCTCCAACCTGATGATGCAGGAGCGCGGCGTCGCGCTGCCGTTCGAGGACCCCGTCACCAACGCGGTCAATGCGGCGCGGCCCATCCTGGACGCGATGTCGCCCGAGGCCCGGGAGCGCATCGAGCTCCTGGTCACCTCGAGCGAGTCCGGCGTGGACTTCAGCAAGTCCATCTCCTCGTATGCGCACGAGCACCTGGGGCTGAGCCGCCACTGCCGGTTCCTGGAGGTGAAGCAGGCGTGTTACGCCGCCACCGGAGCGCTCCAGCTAGCGCTGGGCTACATCGCGTCGGGCGTGTCACCGGGGGCCAAGGCCCTGGTGATTGCCACGGACGTGACGCTGGTGGACGAGAGCGGTCTGTACTCCGAGCCGGCGATGGGCACCGGCGGCGTCGCCGTGCTGCTGGGCGACGAGCCGCGCGTGATGAAGATGGACCTGGGAGCGTTCGGCAACTACAGCTACGACGTCTTCGACACCGCGCGGCCCTCGCCGGAGATTGATATCGGCGACGTGGACCGGTCGCTCTTCACGTACCTGGACTGCCTCAAGCACAGCTTCGCCGCGTATGGCCGCCGGGTGGACGGTGTCGACTTCGTGTCGACGTTCGACTACCTGGCGATGCACACGCCGTTCGCCGGACTGGTGAAGGCCGGGCACCGCAAGATGATGCGCGAGCTCACCCCGTGCGACGTGGACGAAATCGAAGCGGACTTCGGCCGGCGCGTGAAGCCGTCACTGCAGTACCCGAGTCTGGTCGGGAACCTGTGCTCCGGCTCCGTGTACCTGAGCCTGTGCAGCATCATCGACACCATCAAGCCCGAGCGGTCCGCTCGGGTGGGAATGTTCTCCTATGGGTCGGGTTGCTCGTCGGAGTTCTTCAGCGGCGTCATCGGCCCGGAGTCCGTGTCCGCGCTAGCTGGGTTGGACATCGGTGGCCACCTCCGGGGGCGCCGCCAGCTCACGTTCGACCAATATGTCGAATTGCTGAAAGAGAACCTTCGCTGTCTGGTTCCAACGAAGAACCGGGACGTGGACGTGGAGCGCTACCTCCCGCTGGTGACGCGGACGGCGAGCCGCCCGCGCATGCTCGCCTTGCGAAGGGTCGTGGACTATCATCGTCAGTACGAGTGGGTGTAG	MAERVPGGVGIEAINAYGGAASIPVLDLFRGRRLDPERFSNLMMQERGVALPFEDPVTNAVNAARPILDAMSPEARERIELLVTSSESGVDFSKSISSYAHEHLGLSRHCRFLEVKQACYAATGALQLALGYIASGVSPGAKALVIATDVTLVDESGLYSEPAMGTGGVAVLLGDEPRVMKMDLGAFGNYSYDVFDTARPSPEIDIGDVDRSLFTYLDCLKHSFAAYGRRVDGVDFVSTFDYLAMHTPFAGLVKAGHRKMMRELTPCDVDEIEADFGRRVKPSLQYPSLVGNLCSGSVYLSLCSIIDTIKPERSARVGMFSYGSGCSSEFFSGVIGPESVSALAGLDIGGHLRGRRQLTFDQYVELLKENLRCLVPTKNRDVDVERYLPLVTRTASRPRMLALRRVVDYHRQYEWV	MTDPRKNGDLHEPATAPATPWSKSELVRQLRDLGVRSGDMVMPHVSLRAVGPLADGPQTLVDALIEAVGPTGNILAFVSWRDSPYEQTLGHDAPPAAIAQSWPAFDPDHAPAYPGFGAINEFIRTYPGCRRTAHPDASMAAIGPDAAWLVAPHEMGAAYGPRSPIARFLAHAGKILSIGAGPDAVTALHYAEAVARIEGKRRVTYSMPLLREGKRVWVTTSDWDSNGILDEYAAPDGPDAVERIARDYLARTRVAQGPVGGAQSRLIDAADIVSFGIEWLEARHAAPAAAALKPKQRRD	139.13	gnl|BL_ORD_ID|1012|hsp_num:0	1105			540	672	sisomicin; 6'-N-ethylnetilmicin; gentamicin
BGC0001104.1|Myxovirescin_8 # 8134 # 8397 # -1 # ID=1_8;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.663	BGC0001104.1|Myxovirescin_8 	8134	8397	-	Loose	500	23.483	OXY-2-15	34.55	3006130	protein homolog model	n/a	n/a	monobactam; cephalosporin; penam	antibiotic inactivation	OXY beta-lactamase	GTGGGTGAGCCGATGACAGACGAACAAATCCGCGGAGTCGTGCACCAGTCCATCGTGCGCGTCCTGCCCCGCGTGCGCTCCAACGAGATTGCGGGCCACTTGAACCTCCGCGAGCTGGGCGCGGACTCCGTGGACCGGGTCGAGATTCTCACGTCCATCCTGGACAGCCTGCGGCTGCAGAAGACGCCACTGGCGAAGTTCGCCGACATCCGCAACATCGACGCGCTGGTGGCGTTCCTGGCCGGTGAGGTCGCGGGTGGCTGA	MGEPMTDEQIRGVVHQSIVRVLPRVRSNEIAGHLNLRELGADSVDRVEILTSILDSLRLQKTPLAKFADIRNIDALVAFLAGEVAGG	MIKSSWRKIAMLAAAVPLLLASGALWASTDAIHQKLTDLEKRSGGRLGVALINTADNSQILYRGDERFAMCSTSKVMAAAAVLKQSESNKEVVNKRLEINAADLVVWSPITEKHLQSGMTLAELSAATLQYSDNTAMNLIIGYLGGPEKVTAFARSIGDATFRLDRTEPNTAIPGDERDTSTPLAMAESLRKLTLGDALGEQQRAQLVTWLKGNTTGGQSIRAGLPESWVVGDKTGAGDYGTTNDIAVIWPEDHAPLILVTYFTQPQQDAKNRKEVLAAAAKIVTEGL	30.21	gnl|BL_ORD_ID|4168|hsp_num:0	5238			489	654	
BGC0001104.1|Myxovirescin_9 # 8390 # 9367 # -1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.681	BGC0001104.1|Myxovirescin_9 	8390	9367	-	Loose	600	25.409	SGM-4	33.9	3006990	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	SGM beta-lactamase	ATGTCCAGCGTAGCGACGGCCGTCCCCCTGACGGCCCGTGACAGCGCGGTGAGCCGCCGGCTGCGAATCACCCCCAGCATGTGCGGCCAGACGTCCTTGTTCGCCGGGCAGATTGGCGACTGGGCATGGGACACCGTCAGCCGCCTGTGTGGCACGGACGTGCTGACCGCGACCAACGCCTCAGGCGCGCCCACCTACCTGGCCTTCTATTACTTCCGCATCCGGGGCACGCCCGCGCTGCATCCCGGCGCGCTGCGCTTCGGCGACACGCTGGACGTCACGTCGAAGGCGTACAACTTCGGCAGCGAATCCGTCCTGACGGTGCACCGCATCTGCAAGACGGCGGAGGGCGGCGCTCCGGAGGCGGATGCCTTCGGCCATGAAGAGCTGTACGAGCAGCCCCAGCCAGGCCGCATCTACGCGGAGACCTTCAACCGGTGGATCACGCGCTCGGACGGCAAGTCGAACGAGAGCCTGATCAAGTCCTCGCCCGTGGGGTTCCAGTACGCACACCTGCCGCTCTTGCCGGACGAATACTCGCCGCGGCGGGCCTATGGGGACGCGCGGGCGCGGGGCACCTTTCACGATGTGGACTCCGCGGAGTACCGGCTGACCGTGGACCGCTTCCCGCTGCGCTACGCGGTGGACGTCATCCGGGACGTCAATGGGGTGGGGCTCATCTACTTCGCGTCGTATTTCTCGATGGTGGACTGGGCCATCTGGCAGCTGGCGAGGCACCAGGGACGCAGCGAGCAGGCCTTCCTGTCGCGCGTGGTGCTGGACCAGCAACTGTGCTTCCTCGGCAACGCGGCGCTGGACACCACCTTCGACATCGACGTGCAGCACTGGGAGCGGGTGGGCGGCGGGGAAGAGCTGTTCAACGTGAAGATGCGCGAGGGCGCGCAGGGCCGGGACATCGCCGTGGCGACGGTCAAGGTGCGCTTCGACGCCGCTTCGGAAGGAGGCCGCCGTGGGTGA	MSSVATAVPLTARDSAVSRRLRITPSMCGQTSLFAGQIGDWAWDTVSRLCGTDVLTATNASGAPTYLAFYYFRIRGTPALHPGALRFGDTLDVTSKAYNFGSESVLTVHRICKTAEGGAPEADAFGHEELYEQPQPGRIYAETFNRWITRSDGKSNESLIKSSPVGFQYAHLPLLPDEYSPRRAYGDARARGTFHDVDSAEYRLTVDRFPLRYAVDVIRDVNGVGLIYFASYFSMVDWAIWQLARHQGRSEQAFLSRVVLDQQLCFLGNAALDTTFDIDVQHWERVGGGEELFNVKMREGAQGRDIAVATVKVRFDAASEGGRRG	MPRRLLLAALLLAGPASAQQEAPRQSLLPPPPRYMVSESAMKSVRNPKEIESESGGRLGVALVDSKGALILGFNRDERFAMCSTFKAPLAAAVLSGAEGNKFGLEGQIGFTKADLLDHAPVVKKNARRGRMSMEELAAAAVEVSDNSAANLLLPMIGGPEGFTRYVRAHGDNVTRLDRTEPALNENAEGDERDTTSPAAMAGLMRRLIFTDLKPESAARLRGWLNASTTGGNRIKAGLPKDWTSGSKTGTCGTAYNDVALVKAPSGEEYILAIYLDRPTVDAKAAEAAIAETARAALDFVGKAQKTGLE	105.18	gnl|BL_ORD_ID|4577|hsp_num:0	5647			654	831	
BGC0001104.1|Myxovirescin_10 # 9390 # 10652 # -1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.673	BGC0001104.1|Myxovirescin_10 	9390	10652	-	Loose	2200	27.335	Bifidobacterium bifidum ileS conferring resistance to mupirocin	36.36	3003730	protein homolog model	n/a	n/a	mupirocin-like antibiotic	antibiotic target alteration	antibiotic-resistant isoleucyl-tRNA synthetase (ileS)	ATGGGGCCGGTCGGGATTGAAGCCATGAATGCCTACTGTGGCATCGCCAGGTTGGATGTGTTGCAGCTGGCGACCCACCGTGGCCTGGACACCTCCCGCTTCGCGAACCTGCTCATGGAGGAGAAGACCGTCCCGCTCCCCTATGAGGACCCTGTCACCTACGGCGTGAATGCCGCCCGGCCCATCCTGGACCAGTTGACCGCGGCGGAACGGGACAGCATCGAGCTGCTGGTGGCTTGCACGGAGTCCTCGTTCGACTTCGGCAAGGCCATGAGCACCTACCTGCACCAGCACCTGGGGCTGAGCCGCAACTGCCGGCTCATCGAGCTCAAGAGCGCCTGCTACTCCGGGGTCGCCGGGCTGCAGATGGCCGTCAACTTCATCCTGTCCGGCGTGTCGCCGGGGGCCAAGGCCCTGGTGGTGGCCTCCGACCTGTCGCGCTTCTCCATCGCCGAAGGGGGAGATGCCTCCACGGAGGACTGGTCCTTCGCGGAGCCGAGCTCGGGTGCGGGCGCGGTGGCCATGCTGGTGAGCGACACGCCCCGGGTGTTCCGCGTCGACGTGGGGGCGAACGGCTACTACGGCTACGAGGTGATGGATACCTGCCGCCCGGTGGCGGACAGCGAAGCGGGAGACGCGGACCTGTCGCTCCTCTCGTACCTGGACTGCTGTGAGAACGCCTTCCGGGAGTACACCCGCCGCGTCCCCGCGGCGAACTACGCGGAGAGCTTCGGCTACCTCGCCTTCCACACGCCGTTTGGCGGCATGGTGAAGGGCGCCCACCGCACGATGATGCGCAAGTTCTCCGGCAAGAACCGCGGGGACATCGAAGCGGACTTCCAGCGGCGAGTGGCCCCCGGGCTGACCTACTGCCAGCGCGTGGGGAACATCATGGGCGCGACGATGGCGCTCTCGCTCCTCGGGACCATCGACCACGGCGACTTCGCCACCGCGAAGCGGATTGGCTGCTTCTCGTATGGCTCGGGGTGCAGCTCGGAGTTCTTCAGCGGCGTGGTGACGGAGGAAGGGCAGCAGCGGCAGCGCGCCCTGGGGCTGGGAGAAGCGCTGGGGCGCCGGCAGCAGCTCTCCATGCCGGATTACGACGCGCTGCTGAAGGGGAACGGCCTGGTGCGCTTCGGGACCCGGAACGCCGAGCTGGATTTCGGTGTCGTCGGCAGCATCCGGCCGGGCGGGTGGGGCAGGCCCTTGCTCTTCTTGTCGGCGATTCGTGACTTCCATCGCGACTACCAATGGATTTCCTAG	MGPVGIEAMNAYCGIARLDVLQLATHRGLDTSRFANLLMEEKTVPLPYEDPVTYGVNAARPILDQLTAAERDSIELLVACTESSFDFGKAMSTYLHQHLGLSRNCRLIELKSACYSGVAGLQMAVNFILSGVSPGAKALVVASDLSRFSIAEGGDASTEDWSFAEPSSGAGAVAMLVSDTPRVFRVDVGANGYYGYEVMDTCRPVADSEAGDADLSLLSYLDCCENAFREYTRRVPAANYAESFGYLAFHTPFGGMVKGAHRTMMRKFSGKNRGDIEADFQRRVAPGLTYCQRVGNIMGATMALSLLGTIDHGDFATAKRIGCFSYGSGCSSEFFSGVVTEEGQQRQRALGLGEALGRRQQLSMPDYDALLKGNGLVRFGTRNAELDFGVVGSIRPGGWGRPLLFLSAIRDFHRDYQWIS	MSETTNSHVYPKANEGGETASVAPNPSFPNMEETVLKYWDKDDTFNKSVERNPSGDHSQNEFVFFDGPPFANGLPHYGHLLTGYAKDVIPRYQTMKGRKVNRVFGWDTHGLPAELEAQKELGIDSVDQIEKMGIDKFNDACRASVLKYTHEWQDYVHRQARWVDFEHGYKTLNIPYMESVMWAFKQLYEKGLAYQGYRVLPYCPKDQTPLSAHELRMDADVYQDRQDTTVSVAVKLRDEEDAYAVFWTTTPWTVPTNFAIVVGADIDYVEVRPTQGKYAGKKFYFGKPLLSKYEKELGEDYEVVRELKGSEMAGWRYWPVFPYFAGDKAESEGNVPGPEGYQIFTADYVDTVEGTGLVHQAPYGEDDMNTLNAHGIKSTDVLDAGCRFTAQCPDYEGMYVFDANKPILRNLRNGDGPLAEIPAEHRAILFQEKSYVHSYPHCWRCATPLIYKPVSSWFVSVTKIKPRLLELNQQINWIPENVKDGQFGKWLANARDWSISRNRFWGSPIPVWVSDDPKYPRVDVYGSLEELKADFGDYPRDKDGNVNMHRPWIDNLTRVNPDDPTGKSHMHRISDVLDCWFESGSMSFAQFHYPFENKEKFEQHFPADYIVEYIGQTRGWFYLLHVMATALFDRPAFKNVICHGIVLGSDGQKMSKHLRNYPDVNGVFDKYGSDAMRWFLMSSPILRGGNLIVTAEGIRDTVRQVMLPVWSSYYFFTLYANAANGGAGFDARQLRADEVAGLPEMDRYLLARTRRLVERVEKSLDEFAISDACDAASDFIDVLTNWYIRNTRDRFWKEDVNAFNTLYTVLEVFMRVLAPLAPMESESVWRGLTGGESVHLADWPYVADEKTGEATELGRVLVDDPALVDAMEKVREIVSGALSLRKAAQIRVRQPLAKLTVVVEDVDAVKAYDEILKSELNIKDIEFCTMEDAGSQGLKIVHELKVNARAAGPRLGKQVQFAIKASKTGAWHVDAATGAPVVETPNGEVALEAGEYELINRVEEENAAEADASVSAALPTGGFVILDTVLTADLEAEGYARDVIRAVQDARKAADLDIADRIALVLTVPSANVADVERFRDLIAHETLATSFAVKEGAELGVEVAKA	37.94	gnl|BL_ORD_ID|4694|hsp_num:0	2278			1473	1572	mupirocin
BGC0001104.1|Myxovirescin_11 # 10662 # 10901 # -1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.600	BGC0001104.1|Myxovirescin_11 	10662	10901	-	Loose	2000	27.335	adeB	47.83	3000775	protein homolog model	n/a	n/a	glycylcycline; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGACAAGAGAATTATTTTCGACATCGTCACCAGCAGTGTTCGGGAGGTGGTACCCGAACTCGAATCACATCCGTTCGAGCCGGAGGATGACCTGGTCGGACTGGGCGCGAACTCGCTCGACCGCGCCGAAATCGTCAACCTCACGCTGGAGAAGCTGGCGCTCAACATCCCCCGGGTCGAGCTGATTGACGCGAAGACCATTGGCGGGCTGGTGGACGTCCTTCACGCGAGGCTGTGA	MDKRIIFDIVTSSVREVVPELESHPFEPEDDLVGLGANSLDRAEIVNLTLEKLALNIPRVELIDAKTIGGLVDVLHARL	MSQFFIRRPVFAWVIAIFIIIFGLLSIPKLPIARFPSVAPPQVNISATYPGATAKTINDSVVTLIERELSGVKNLLYYSATTDTSGTAEITATFKPGTDVEMAQVDVQNKIKAVEARLPQVVRQQGLQVEASSSGFLMLVGINSPNNQYSEVDLSDYLVRNVVEELKRVEGVGKVQSFGAEKAMRIWVDPNKLVSYGLSISDVNNAIRENNVEIAPGRLGDLPAEKGQLITIPLSAQGQLSSLEQFKNISLKSKTNGSVIKLSDVANVEIGSQAYNFAILENGKPATAAAIQLSPGANAVKTAEVVRAKIEELKLNLPEGMEFSIPYDTAPFVKISIEKVIHTLLEAMVLVFIVMYLFLHNVRYTLIPAIVAPIALLGTFTVMLLAGFSINVLTMFGMVLAIGIIVDDAIVVVENVERIMATEGLSPKDATSKAMKEITSPIIGITLVLAAVFLPMAFASGSVGVIYKQFTLTMSVSILFSALLALILTPALCATILKPIDGHHQKKGFFAWFDRSFDKVTKKYELMLLKIIKHTVPMMVIFLVITGITFTGMKYWPTAFMPEEDQGWFMTSFQLPSDATAERTRNVVNQFENNLKDNPDVKSNTTILGWGFSGAGQNVAVAFTTLKDFKERTSSASKMTSDVNSSMANSTEGETMAVLPPAIDELGTFSGFSLRLQDRANLGMPALLAAQDELMAMAAKNKKFYMVWNEGLPQGDNISLKIDREKLSAFGVKFSDVSDIISTSMGSMYINDFPNQGRMQQVIVQVEAKSRMQLKDILNLKVMGSSGQLVSLSEVVTPQWNKAPQQYNRYNGRPSLSIAGIPNFDTSSGEAMREMEQLIAKLPKGIGYEWTGISLQEKQSESQMAFLLGLSMLVVFLVLAALYESWAIPLSVMLVVPLGIFGAIIAIMSRGLMNDVFFKIGLITIIGLSAKNAILIVEFAKMLKEEGMSLIEATVAAAKLRLRPILMTSLAFTCGVIPLVIASGASSETQHALGTGVFGGMISATILAIFFVPVFFIFILGAVEKLFSSKKKISS	7.63	gnl|BL_ORD_ID|800|hsp_num:0	866			885	954	tigecycline; tetracycline
BGC0001104.1|Myxovirescin_12 # 10975 # 11481 # -1 # ID=1_12;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.631	BGC0001104.1|Myxovirescin_12 	10975	11481	-	Loose	250	25.0238	arr-1	38.1	3002846	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin ADP-ribosyltransferase (Arr)	ATGCCTGGGCCGCGGTGTGCTGAGAACGATTGGGTTGCATTGCTCGTCCGCGTCAATCACGAGAAAGTGGCTGCCGCTCAGTTGGGGAAACACGGCTACGAGTTCTTCCTGCCGACGTACACGCCTCCCAAGTCCTCGGGTGTGAAGGCGAAGCTTCCGCTCTTCCCCGGGTACCTTTTCTGTCGTTACCAGCCGCTCAATCCGTACCGCATCGTCCGGGCGCCCGGGGTCATCCGGCTGCTCGGAGGTGACGCGGGGCCGGAAGCCGTGCCCGCACAGGAATTGGAGGCCATCCGCCGGGTCGCGGATTCGGGTGTCTCTTCCAATCCCTGTGACTATCTGCGGGTGGGGCAGCGCGTGCGCATCATCGAAGGGCCCCTGACAGGTCTGGAAGGAAGTCTGGTGACGAGCAAGAGCCAACTCCGGTTCATTGTCTCCGTGGGGCTGCTACAGCGCTCGGTGTCCGTGGAGGTGAGCGCCGAGCAACTGGAACCGATCACCGACTGA	MPGPRCAENDWVALLVRVNHEKVAAAQLGKHGYEFFLPTYTPPKSSGVKAKLPLFPGYLFCRYQPLNPYRIVRAPGVIRLLGGDAGPEAVPAQELEAIRRVADSGVSSNPCDYLRVGQRVRIIEGPLTGLEGSLVTSKSQLRFIVSVGLLQRSVSVEVSAEQLEPITD	MVANPPKPFEVHESGAYLHGTKADLKVGDRLVPGRESNFEAGRIMKHVYITQTLDAAVWGAELAVGEGRGRIYIVEPEGEIEDDPNVTDKKLPGNPTRSYRTREPVRIVGELTDWEGHSPEQIAAMREGLEDLRRKGLAVIYD	117.48	gnl|BL_ORD_ID|1801|hsp_num:0	1950			228	351	rifampin; rifaximin; rifabutin; rifapentine
BGC0001104.1|Myxovirescin_3 # 1555 # 2808 # -1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.697	BGC0001104.1|Myxovirescin_3 	1555	2808	-	Loose	310	25.409	Type B NfxB	29.55	3004060	protein overexpression model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; cephalosporin; penam; tetracycline antibiotic; aminocoumarin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGTCCACCTCACCTGTGCAGGAGCTGGTTGTCTCGGGGTTCGGGGTCACCTCCGCCATTGGCCAGGGGGCCGCGTCCTTCACCTCGGCGCTGCTGGAGGGCGCGGCACGGTTCCGGGTGATGGAGCGGCCGGGCCGTCAGCATCAGGCCAACGGGCAGACGACGGCCCACCTGGGGGCGGAAATCGCCTCGCTGGCCGTGCCCGAAGGCGTCACCCCACAACTGTGGCGCTCGGCCACGTTTTCGGGGCAGGCCGCACTGGTGACCGTCCACGAGGCCTGGAACGCGGCGCGCCTCCAGGCCGTCCCCGGACACCGGATTGGATTGGTGGTGGGGGGCACCAACGTGCAGCAGCGCGACCTGGTGCTGATGCAAGACGCCTATCGCGAGCGGGTGCCCTTTCTGCGGGCGGCCTACGGGTCGACCTTCATGGACACCGACCTCGTGGGCCTCTGCACGCAGCAGTTCGCCATCCACGGGATGTCCTTCACGGTGGGAGGCGCATCGGCCAGTGGCCTGCTGGCGGTCATCCAGGCCGCGGAGGCGGTGCTCTCAAGAAGGGTGGACGTTTGCATCGCCGTGGGGGCGCTGATGGACGTCTCCTACTGGGAATGCCAGGGCCTGCGGGCCATGGGCGCGATGGGCACCGACCGGTTCGCGCGGGAGCCGGAGCGTGCCTGCCGGCCCTTCGACCGGGAGAGTGATGGCTTCATCTTTGGAGAGGCGTGCGGCGCCGTGGTGGTTGAGTCTGCGGAGCACGCTCGGCGACGCGGGGTGACTCCTCGCGGCATCCTGTCGGGCTGGGCCATGCAGTTGGACGCGAGCCGCGGCCCGTTGTCGTCCATCGAAGGGGAGTCGCAGGTGATTGGGGCTGCGCTGCGGCACGCGGACCTCGCGCCGGAGCGGGTGGACTACGTGAATCCTCACGGCAGCGGTTCGCGTCAGGGGGATGCCATCGAGCTGGGGGCCTTGAAGGCGTGCGGCCTGACGCACGCCCGGGTCAACACCACGAAGTCCATCACCGGGCATGGCCTGTCCTCGGCGGGTGCCGTGGGGCTCATCGCCACGCTGGTCCAGTTGGAGCAGGGCCGGCTGCACCCGTCCTTGAACCTGGTGGACCCGATTGATTCATCGTTCCGCTGGGTGGGGGCCACCGCGGAGGCCCAGTCCCTCCAGAACGCGCTGGTGCTCGCCTACGGCTTCGGCGGCATCAACACCGCTGTCGCCGTGCGCCGGAGCGCCACGGAGAGCTGA	MSTSPVQELVVSGFGVTSAIGQGAASFTSALLEGAARFRVMERPGRQHQANGQTTAHLGAEIASLAVPEGVTPQLWRSATFSGQAALVTVHEAWNAARLQAVPGHRIGLVVGGTNVQQRDLVLMQDAYRERVPFLRAAYGSTFMDTDLVGLCTQQFAIHGMSFTVGGASASGLLAVIQAAEAVLSRRVDVCIAVGALMDVSYWECQGLRAMGAMGTDRFAREPERACRPFDRESDGFIFGEACGAVVVESAEHARRRGVTPRGILSGWAMQLDASRGPLSSIEGESQVIGAALRHADLAPERVDYVNPHGSGSRQGDAIELGALKACGLTHARVNTTKSITGHGLSSAGAVGLIATLVQLEQGRLHPSLNLVDPIDSSFRWVGATAEAQSLQNALVLAYGFGGINTAVAVRRSATES	MTLISHDERLIKALAVAIVDRPRATLKELAEAAGVSKATLHRFCGTRDNLVQMLEDHGETVLNQIIQACDLEHAEPLEALQRLIKEHLTHRELLVFLVFQYRPDFLDPHGEGARWQSYLEALDAFFLRGQQKGVFRIDITAAVFTELFITLVYGMVDAERRGRAASSNSAHTLEQMFLHGASNPARS	222.99	gnl|BL_ORD_ID|2342|hsp_num:0	2693			228	360	erythromycin; gentamicin C; tetracycline; novobiocin; trimethoprim; chloramphenicol; ofloxacin; gentamicin
